Please login to the form below

Not currently logged in
Email:
Password:

OPEN Health acquires Lane Earl Cox

Recently launched healthcare communications firm OPEN Health has bought Lane Earl Cox, which will be rebranded as OPEN LEC

Healthcare advertising agency Lane Earl Cox (LEC) has been acquired by communications company OPEN Health, which was launched in January 2011.

Lane Earl Cox (LEC) will be rebranded as OPEN LEC. Matthew Baker, formerly deputy managing director of LEC, becomes MD of OPEN LEC, as well as taking a partnership in OPEN Health.

This sees him re-united with former Huntsworth Health colleagues David Rowley, Sandy Royden and Marcus Perry. Mike Lane and David Earl, founder members of LEC, will become consultants to the business.

David Rowley, partner of OPEN Health, said: "This is an exciting opportunity. LEC are a well known and respected agency and together we form a team with amazing expertise and experience ready to face the challenges of healthcare communications today and tomorrow."

OPEN Health has also appointed Margot Rozga as associate partner. Rozga's primary responsibility will be to build the medical communications business with Sandy Royden.

LEC was established in 1993 and has worked on brands including Lipitor, Losec, Vioxx, Aricept, Symbicort, Atripla and Prozac.

7th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics